Piper Sandler Reaffirms “Overweight” Rating for Oscar Health (NYSE:OSCR)

Oscar Health (NYSE:OSCR)‘s stock had its “overweight” rating reissued by Piper Sandler in a report issued on Tuesday, Benzinga reports. They currently have a $28.00 price target on the stock. Piper Sandler’s price objective suggests a potential upside of 59.82% from the stock’s previous close.

Other research analysts have also recently issued reports about the company. Bank of America reissued a “neutral” rating and set a $21.00 price target (down from $25.00) on shares of Oscar Health in a research report on Thursday, May 30th. Baird R W raised Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th. Robert W. Baird started coverage on shares of Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price on the stock. Finally, Wells Fargo & Company lifted their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Wednesday, June 12th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $24.17.

Oscar Health Stock Up 0.3 %

Shares of NYSE OSCR traded up $0.05 during midday trading on Tuesday, reaching $17.52. The company’s stock had a trading volume of 571,858 shares, compared to its average volume of 3,196,997. The stock has a 50 day simple moving average of $17.01 and a 200-day simple moving average of $17.24. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $4.24 billion, a price-to-earnings ratio of -43.55, a PEG ratio of 33.66 and a beta of 1.61. Oscar Health has a fifty-two week low of $4.72 and a fifty-two week high of $23.44.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The firm had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. During the same period in the previous year, the business earned ($0.07) EPS. The company’s revenue was up 44.6% compared to the same quarter last year. Equities research analysts predict that Oscar Health will post 0.01 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Richard Scott Blackley sold 68,978 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now owns 884,213 shares of the company’s stock, valued at $15,906,991.87. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock worth $3,007,069 over the last ninety days. Insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

A number of institutional investors have recently bought and sold shares of the business. Avalon Trust Co acquired a new position in Oscar Health in the first quarter valued at about $69,000. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health in the 2nd quarter valued at approximately $78,000. Prevail Innovative Wealth Advisors LLC bought a new stake in shares of Oscar Health during the 4th quarter worth approximately $92,000. Quest Partners LLC acquired a new stake in shares of Oscar Health during the 2nd quarter worth approximately $93,000. Finally, Amalgamated Bank increased its stake in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after acquiring an additional 1,458 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.